×
About 3,048 results

ALLMedicine™ Myopathy Center

Research & Reviews  1,483 results

Successful Plasmapheresis and Immunoglobulin treatment for severe lipid storage myopath...
https://doi.org/10.1111/nan.12731
Neuropathology and Applied Neurobiology; Kleefeld F, von Renesse A et. al.

May 10th, 2021 - Lipid myopathies are rare and heterogeneous multi-systemic diseases that may be hereditary or acquired and affect the skeletal muscle [1]. Four types usually demonstrate accumulation of lipids in muscle biopsy specimens that can be visualised usin...

ACTG2 Visceral Myopathy - GeneReviews® - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/n/gene/actg2-dis/

May 5th, 2021 - ACTG2 visceral myopathy is a disorder of smooth muscle dysfunction of the bladder and gastrointestinal system with phenotypic spectrum that ranges from mild to severe. Bladder involvement can range from neonatal megacystis and megaureter (with its...

Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082920
BMC Pediatrics; Zhang G, Xu M et. al.

Apr 30th, 2021 - Centronuclear myopathy (CNM), a subtype of congenital myopathy (CM), is a group of clinical and genetically heterogeneous muscle disorders. Since the discovery of the SPEG gene and disease-causing variants, only a few additional patients have been...

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012169
Clinical Neurophysiology : Official Journal of the Intern... Frithiof R, Rostami E et. al.

Apr 20th, 2021 - The aim was to characterize the electrophysiological features and plasma biomarkers of critical illness polyneuropathy (CIN) and myopathy (CIM) in coronavirus disease 2019 (COVID-19) patients with intensive care unit acquired weakness (ICUAW). An ...

Statin-induced necrotising autoimmune myopathy: a rare complication of statin therapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054048
BMJ Case Reports; Ghaffar MT, Radhakrishna A et. al.

Apr 16th, 2021 - Statin-induced necrotising autoimmune myopathy (SINAM), a rare complication of statin use, presents with significant proximal muscle weakness and raised creatine kinase (CK) levels (50-100 times). This is different from other musculoskeletal condi...

see more →

Guidelines  2 results

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
https://www.bmj.com/content/372/bmj.n135
BMJ Herrett E, .

Feb 22nd, 2021 - Statins reduce cardiovascular disease events in primary and secondary prevention, in men and women, and across all age groups.12 Systematic reviews and meta-analyses of randomised trials have confirmed the safety of statins.3 Although severe adver...

An Official American Thoracic Society Clinical Practice Guideline: The Diagnosis of Intensiv...
http://www.thoracic.org/statements/resources/cc/ICUAW_cpg.pdf
Eddy Fan

Dec 14th, 2014 - Research that identifies treatments that benefit patients with ICUAW is necessary to determine whether the benefits of diagnostic testing for ICUAW outweigh its burdens.

see more →

Drugs  21 results see all →

Clinicaltrials.gov  1,529 results

Successful Plasmapheresis and Immunoglobulin treatment for severe lipid storage myopath...
https://doi.org/10.1111/nan.12731
Neuropathology and Applied Neurobiology; Kleefeld F, von Renesse A et. al.

May 10th, 2021 - Lipid myopathies are rare and heterogeneous multi-systemic diseases that may be hereditary or acquired and affect the skeletal muscle [1]. Four types usually demonstrate accumulation of lipids in muscle biopsy specimens that can be visualised usin...

ACTG2 Visceral Myopathy - GeneReviews® - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/n/gene/actg2-dis/

May 5th, 2021 - ACTG2 visceral myopathy is a disorder of smooth muscle dysfunction of the bladder and gastrointestinal system with phenotypic spectrum that ranges from mild to severe. Bladder involvement can range from neonatal megacystis and megaureter (with its...

Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082920
BMC Pediatrics; Zhang G, Xu M et. al.

Apr 30th, 2021 - Centronuclear myopathy (CNM), a subtype of congenital myopathy (CM), is a group of clinical and genetically heterogeneous muscle disorders. Since the discovery of the SPEG gene and disease-causing variants, only a few additional patients have been...

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012169
Clinical Neurophysiology : Official Journal of the Intern... Frithiof R, Rostami E et. al.

Apr 20th, 2021 - The aim was to characterize the electrophysiological features and plasma biomarkers of critical illness polyneuropathy (CIN) and myopathy (CIM) in coronavirus disease 2019 (COVID-19) patients with intensive care unit acquired weakness (ICUAW). An ...

Statin-induced necrotising autoimmune myopathy: a rare complication of statin therapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054048
BMJ Case Reports; Ghaffar MT, Radhakrishna A et. al.

Apr 16th, 2021 - Statin-induced necrotising autoimmune myopathy (SINAM), a rare complication of statin use, presents with significant proximal muscle weakness and raised creatine kinase (CK) levels (50-100 times). This is different from other musculoskeletal condi...

see more →

News  11 results

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
https://www.bmj.com/content/372/bmj.n135
BMJ Herrett E, .

Feb 22nd, 2021 - Statins reduce cardiovascular disease events in primary and secondary prevention, in men and women, and across all age groups.12 Systematic reviews and meta-analyses of randomised trials have confirmed the safety of statins.3 Although severe adver...

Stealth Bio's neuromuscular disorder drug fails trial; shares plummet
https://www.reuters.com/article/us-stealth-biothera-study/stealth-bios-neuromuscular-disorder-drug-fails-trial-shares-plummet-idUSKBN1YO1JG

Dec 20th, 2019 - (Reuters) - Stealth BioTherapeutics Corp’s shares crashed on Friday after its lead neuromuscular disorder drug candidate failed to help patients walk better and reduce fatigue, a major setback to the company’s wide mitochondrial diseases pipeline....

Idiopathic Inflammatory Myopathy Quadruples Death Risk
https://www.medpagetoday.com/rheumatology/generalrheumatology/67519

Aug 26th, 2017 - Action Points A Swedish population-based study found a nearly fourfold greater risk of all-cause mortality in idiopathic inflammatory myopathy (IIM) patients compared with the general population. Note that apart from musculoskeletal and connective...

Widespread Muscle Involvement in Necrotizing Myopathy
https://www.medpagetoday.com/rheumatology/generalrheumatology/60464

Sep 26th, 2016 - Action Points Muscle involvement in immune-mediated necrotizing myopathy (IMNM) was more extensive compared with that in polymyositis (PM) and dermatomyositis (DM), and IMNM patients with anti-signal recognition particle (SRP) autoantibodies had m...

HPS2-THRIVE: High Myopathy Risk With Niacin/Laropiprant
https://www.staging.medscape.com/viewarticle/779957

Feb 26th, 2013 - (Updated) OXFORD, UK — New data shed some light on the adverse events associated with extended-release niacin and the antiflushing agent laropiprant in the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-...

see more →

Patient Education  2 results see all →